Objective: The aim of this study was to examine adherence of state guidelines for Colorado workers' compensation physicians/providers treating individuals as injured workers with chronic pain after initiation of an opioid management program and provider incentives.
guidelines on clinical practice and patient outcomes; with some evidence that practitioners may still lack awareness or fail to modify their approach to patient care. 30 
| New guidelines & provider education
In 2010, the Colorado Division of Workers' Compensation in the State Department of Labor and Employment took a three-pronged approach to start to address these challenges. They updated the medical treatment guidelines for chronic pain disorder and added education sessions to accreditation courses for practitioners who treat workers' compensation patients and to other regional conferences, and added a new billing code to the Colorado workers' compensation medical fee schedule. 31 The new billing code became effective January 1, 2010, and The total MED per prescription was then determined using the following formula:
where D in the MED in mg, c is the number of pills (or patches) in the prescription, d is the dose (mg) of an opioid drug in a pill (or patch), and r is the conversion ratio of morphine for the specific opioid medication. 3 | RESULTS Table 3 presents the number of claims with evidence of opioid monitoring and/or documentation of chronic opioid management reporting introduced in 2010 including psychiatric consults, urine drug screens, and use of a Z-code. The most commonly implemented management elements were psychiatric consults (32%), followed by drug screens (16%), and chronic opioid management report with the associated reimbursement Z-code (12.5%). 32 We observed comprehensive opioid management, including psychiatric consults, drug screens, and active opioid management, in only 4.4% of claims. Claims prescribed LA and SA opioids were more likely to receive some type of opioid management and were more likely to receive comprehensive opioid management (6.5%), than were claims prescribed SA opioids only. Table 4 Our data confirm previous studies that have examined SA versus LA opioid prescribing and dose. The patients that were prescribed LA (40% of total) had nearly a 2.5 times higher average MED per day than those that were prescribed SA opioids only (16.8 vs 7.15 mg/day). The difference between the SA and LA groups was significant across the life of the claim, confirming that all patients prescribed LA are prescribed a higher MED during treatment. Additionally, we noted that claims that billed for a Z-code were more likely to have ever been prescribed both LA and SA opioids and had a MED of 11.6 mg/day higher than those that did not bill for a Z-code. opioids. 35, 36 However, it is also probable that LA were prescribed for the more severe injuries, which is not adjusted for in our analysis
| Examination of opioid use as claim matures

| Examination of opioid management program effects
Our evaluation confirms the early findings of Franklin (2012) highlighting the limited impact of state-based medical treatment guidelines implemented in workers' compensation and shows that by providing physician incentives in the form of a new billing code, assuming increased awareness and adoption among providers, temporary decreases in mean MED per claim were achievable even at the time that opioid prescribing practices were peaking nationally.
The observed short-term effects suggest that there was an increase in awareness initially among the practitioner cohort in our study, but that still insufficient relative to the time and expectations that chronic pain management cases require. One possible conclusion drawn from this study is that changing provider behavior might require an ongoing mechanism to remind and monitor providers so they consistently utilize the coding, consult, and drug test tools. This warrants future research and an intervention design that is tailored to physicians and evaluates the reach, effectiveness, implementation, awareness, and maintenance of desired changes.
| Study limitations
There are several limitations to this study. Because we conducted the evaluation retrospectively, we were not able to design the intervention and evaluate its implementation. We cannot exclude the possibility Omission of other covariates and confounders is an inherent limitation.
Recent studies have shown that MED dose calculation can be used reliably in some cases, but there can be a wide range of dose estimations across provider groups. 37 The calculation also does not account for other prescriptions that individuals received, or any pharmacologic and nonpharmacologic responses that may affect drug metabolism. Many workers in this dataset may have access to health insurance offered through their employer. This could cause our calculations of opioid dosage to underestimate the true MED in these cases.
We also do not have data on pre-existing mental health issues in this cohort and we have no way of distinguishing mental health issues that are related to work-related injury. We have no reason to think that the frequency of these referrals would change over time and in relation to other mental health issues and therefore do not think this would introduce systematic bias.
The way we measured provider adherence to the guidelines assumes that if the injured worker received opioids and there was no code billed for the psychiatric evaluation, the primary referring doctor did not refer/test, and that therefore they are prescribing the chronic pain patient opioids without following the guidelines. We do not know whether this was because providers failed to order consults/tests or whether patients were noncompliant with provider orders. It is possible that the level of additional time, effort, and complication involved in adding a Z-code may have led coders to not bill the Z-code, even though the added services were provided. We have no evidence to indicate that this is the case, and other Z-codes are commonly available, so it is not a unique billing activity.
| CONCLUSIONS
The main intent of this study was to examine adherence of Colorado workers' compensation providers to chronic pain guidelines after initiation of an opioid management program that included incentives for physicians treating injured workers. We sought to test this intervention's effect on opioid dosing, type of opioid (SA and LA), and claim duration at a unique time when the U.S. was experiencing an historical peak in the use of prescription opioids, but prior to widespread public and physician awareness campaigns.
We observed a significant, but only temporary decrease in opioid dose and LA prescriptions with the introduction of an opioid management program and billing instrument. We conclude that more robust prescriber education along with other interventions may be required to improve adherence to current pain management guidelines.
The state of Colorado has been one of many states to develop wide reaching approaches to help curb the prescription drug epidemic. In 2013, the Colorado Governor's Office signed a new comprehensive plan to combat the opioid crisis in the state, establishing the official Colorado Consortium for Prescription Drug Abuse Prevention. 38 One of the major efforts of the consortium's provider and prescriber education work group has been to change state board policies (or rules) for licensed prescribers to include opioid management guidelines that cover safe use, safe storage and safe disposal.
As a next step, provider and prescriber education needs to be supported and promoted by all health care providers, including those in the field of occupational medicine. Consistency of educational content and guidelines should focus not just on dosing but also on comprehensive approaches to assessing and improving patient function through evidence-based strategies including the use of non-opioid or alternative therapies prior to prescribing opioids. Future efforts should also consider provider behavior change and the need to tailor interventions to this audience. Tracking prescribing patterns by specialists, by geographic region, and by types of case (claim) will assist in directing resources to the providers and practices that lack training and tools. This study is one step toward understanding more about prescribing patterns and opportunities to improve non-cancer chronic pain management in injured workers. Finally, it should be acknowledged that although there is a national epidemic of opioid misuse, abuse, and diversion warranting careful consideration of who should be treated with chronic opioids, there are many workers who are able to remain gainfully employed and who require chronic treatment to remain employed.
AUTHORS' CONTRIBUTIONS
LT and LMM contributed equally to the conduct of this research and manuscript as co-first authors. KM and LSN helped conceive the project. BM contributed to the writing of the manuscript. All authors reviewed the results and contributed to the final manuscript. All authors agree to be accountable for all aspects of the work.
